Professor Ying Fan: Evolution of HR+/HER2- Early Breast Cancer Adjuvant Treatment Strategies and Risk Stratification—Based on the Chinese Perspective
Editor's Note Breast cancer is the most common malignancy in women, with an increasing incidence in recent years. HR+/HER2- breast cancer accounts for approximately 70% of all breast cancer cases,…